4-(2,4-Difluorobenzoyl)-piperidine hydrochloride

We are 4-(2,4-Difluorobenzoyl)-piperidine hydrochloride CAS:106266-04-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(2,4-Difluorobenzoyl)-piperidine hydrochloride
CAS.NO:106266-04-0
Synonyms:4-(2,4-Difluorobenzoyl)-piperidine hydrochloride
(2,4-difluorophenyl)-piperidin-4-ylmethanone,hydrochloride
4-(2,4-Difluorobenzoyl)piperidine hydrochloride
 
Physical and Chemical Properties:
Density 1,02 g/cm3
Boiling Point 122°C 9mm
Melting Point 203-206°C (dec.)
Molecular Formula C12H14ClF2NO
Molecular Weight 261.695
Flash Point 102°C
 
Specification:
Appearance:Off-white to light yellow powder
Appearance of solution:Clear and colorless
Assay:98.5%-101.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Risperidone(CAS:106266-06-2).

4-(2,4-Difluorobenzoyl)-piperidine hydrochloride


Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.2-Ethoxy-3-methylpyrazine These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.(1S,3R,4S,5S)-4,6,6-trimethylbicyclo[3.1.1]heptane-3,4-diol Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.221180-26-3 Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.

Related Products
Product Name
5-Fluoro-2-methoxypyridine View Details
Propylsulfamide potassium View Details
N-Hydroxysuccinimide View Details
2-(4-Fluorophenyl)-5-[(5-iodo-2-Methylphenyl)methyl]thiophene manufacturer 2-Methoxyphenylboronic acid manufacturer 2,4-Difluorotoluene manufacturer Uridine-5′-diphosphoglucose disodium salt manufacturer 1-(2-Bromoethoxy)-4-nitrobenzene manufacturer